Name: Zenas BioPharma, Inc. (ZBIO) Balance Sheet
Creator: FinSpry

Zenas BioPharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Zenas BioPharma, Inc. (ZBIO) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	319.74	56.86	67.21
Short-Term Investments	31.02	0.00	0.00
Cash & Short-Term Investments	350.77	56.86	67.21
Accounts Receivable	0.00	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	5.07	2.95	1.24
Total Current Assets	355.92	59.80	68.44
Non-Current Assets
Property, Plant & Equipment (Net)	1.19	1.01	1.80
Other Non-Current Assets	0.22	0.19	4.33
Total Non-Current Assets	14.05	8.38	6.14
Total Assets	369.97	68.18	74.58
Current Liabilities
Accounts Payable	17.14	5.40	5.82
Short-Term Debt	1.57	0.00	0.00
Accrued Liabilities	30.85	11.88	19.44
Other Current Liabilities	38.38	0.00	0.00
Total Current Liabilities	57.29	23.26	25.97
Non-Current Liabilities
Long-Term Debt	0.22	20.30	0.81
Other Non-Current Liabilities	0.00	0.00	0.00
Total Non-Current Liabilities	0.22	270.64	240.90
Total Liabilities	57.51	293.90	26.78
Stockholders' Equity
Common Stock	0.00	0.00	0.00
Retained Earnings	-387.39	-230.40	-193.28
Accumulated Other Comprehensive Income	0.19	0.04	-0.04
Additional Paid-in Capital	699.65	4.65	1.03
Shares Outstanding	41.79	39.79	39.79
Total Stockholders' Equity	312.46	-225.72	47.80
Total Liabilities & Equity	369.97	68.18	74.58